Total Payments
$8,976
2024 Payments
$1,497
Companies
55
Transactions
467
Medicare Patients
312
Medicare Billing
$59,396
Payment Breakdown by Category
Food & Beverage$8,728 (97.2%)
Education$174.98 (1.9%)
Other$73.07 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,728 | 459 | 97.2% |
| Education | $174.98 | 3 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73.07 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,001 | 69 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $844.40 | 42 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $616.97 | 30 | $0 (2024) |
| Lilly USA, LLC | $584.64 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $469.54 | 21 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $427.78 | 25 | $0 (2024) |
| EMD Serono, Inc. | $370.85 | 16 | $0 (2023) |
| UPSHER-SMITH LABORATORIES LLC | $294.60 | 17 | $0 (2022) |
| Amgen Inc. | $281.08 | 17 | $0 (2023) |
| Biogen, Inc. | $264.69 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,497 | 64 | ABBVIE INC. ($261.95) |
| 2023 | $875.64 | 43 | Teva Pharmaceuticals USA, Inc. ($139.86) |
| 2022 | $1,964 | 110 | ABBVIE INC. ($354.37) |
| 2021 | $1,944 | 112 | AbbVie Inc. ($244.99) |
| 2020 | $1,118 | 60 | Upsher-Smith Laboratories LLC ($152.18) |
| 2019 | $1,423 | 77 | Teva Pharmaceuticals USA, Inc. ($144.92) |
| 2018 | $154.00 | 1 | BOSTON SCIENTIFIC CORPORATION ($154.00) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological), INBRIJA | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Musculoskeletal | ||||||
| 10/28/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/22/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: EPILEPSY | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Neurology | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $36.72 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $42.40 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.60 | General |
| Category: NEUROLOGY | ||||||
| 08/26/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: EPILEPSY | ||||||
| 08/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: PAIN | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Neurology | ||||||
| 07/30/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $39.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 81 | $32,000 | $11,061 |
| 2022 | 4 | 78 | 115 | $41,350 | $14,924 |
| 2021 | 4 | 120 | 218 | $79,880 | $23,969 |
| 2020 | 4 | 63 | 85 | $26,905 | $9,442 |
Total Patients
312
Total Services
499
Medicare Billing
$59,396
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 49 | $19,600 | $7,036 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,000 | $2,216 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 18 | $5,400 | $1,809 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 53 | $21,200 | $8,116 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $9,500 | $3,515 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 28 | $8,400 | $2,871 | 34.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 12 | 15 | $2,250 | $422.22 | 18.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 93 | $42,602 | $13,591 | 31.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 30 | 30 | $14,712 | $5,705 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 35 | $9,266 | $2,932 | 31.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 31 | 60 | $13,300 | $1,741 | 13.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $9,272 | $3,361 | 36.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 38 | $8,588 | $3,306 | 38.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 15 | $7,095 | $1,951 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $1,950 | $822.81 | 42.2% |
About Dr. Casey Nazor, M.D
Dr. Casey Nazor, M.D is a Neurology healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1346503323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Casey Nazor, M.D has received a total of $8,976 in payments from pharmaceutical and medical device companies, with $1,497 received in 2024. These payments were reported across 467 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,728).
As a Medicare-enrolled provider, Nazor has provided services to 312 Medicare beneficiaries, totaling 499 services with total Medicare billing of $59,396. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Kirkland, WA
- Active Since 06/24/2012
- Last Updated 07/31/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1346503323
Products in Payments
- UBRELVY (Drug) $746.52
- NUPLAZID (Drug) $616.97
- RYTARY (Drug) $427.78
- EMGALITY (Drug) $396.52
- KESIMPTA (Drug) $300.00
- AUSTEDO (Drug) $286.26
- INBRIJA (Drug) $248.10
- Trudhesa (Drug) $238.44
- VALTOCO (Drug) $226.45
- QULIPTA (Drug) $220.34
- Aimovig (Biological) $188.63
- Briviact (Drug) $168.61
- VYEPTI (Biological) $164.78
- AMYVID (Drug) $156.05
- GENERAL DBS (Device) $154.00
- TYSABRI (Biological) $147.26
- NUEDEXTA (Drug) $145.12
- NURTEC ODT (Drug) $141.49
- AJOVY (Biological) $133.57
- ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION (Drug) $133.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Kirkland
Dr. Jason Poon, M.d, M.D
Neurology — Payments: $97,966
Neurology $97,966
Dr. Arash Fazl, M.d. , Ph.d, M.D. , PH.D
Neurology — Payments: $39,994
Neurology $39,994
James Song, M.d, M.D
Neurology — Payments: $30,735
Neurology $30,735
Dr. Zeyad Morcos, Md, MD
Neurology — Payments: $14,243
Neurology $14,243
Dr. Alida Griffith, Md, MD
Neurology — Payments: $8,302
Neurology $8,302
Dr. Daniel Burdick, Md, MD
Neurology — Payments: $6,269
Neurology $6,269